| Literature DB >> 10505028 |
A Balci1, P Huusko, K Pääkkönen, V Launonen, A Uner, A Ekmekçi, R Winqvist.
Abstract
Since the identification of the BRCA1 and BRCA2 breast-ovarian cancer susceptibility genes, mutation analyses have been carried out in different populations. Here we screened 15 Turkish breast and breast-ovarian cancer families for mutations in both genes by conformation-sensitive gel electrophoresis (CSGE) and the protein truncation test (PTT), followed by DNA sequencing. Three families included a male breast cancer case, one without family history. Three germline mutations were identified, two in BRCA1 and one in BRCA2. The two BRCA1 mutations, 5382insC and 5622C-->T, were found in breast-ovarian cancer families. The BRCA2 3414delTCAG is a novel mutation detected in a site-specific breast cancer family that included 1 case of male breast cancer. These first results of Turkish families show that the frequency of germline BRCA1 or BRCA2 mutations appears to be high in families with at least 3 breast and/or ovarian cancer cases.Entities:
Mesh:
Substances:
Year: 1999 PMID: 10505028 DOI: 10.1016/s0959-8049(99)00014-3
Source DB: PubMed Journal: Eur J Cancer ISSN: 0959-8049 Impact factor: 9.162